Breast cancer expert Xiaohe Yang, MD, PhD, tackles this complex disease and the many factors involved in its treatment, prevention, and progression. Xiaohe Yang, MD, PhD, knows there is not a “one-size-fits-all” cure for breast cancer. He and his research team are instead identifying the factors involved in different breast cancer subtypes, testing novel preventative […]
Zhikun Ma, Amanda B. Parris, Zhengzheng Xiao, Erin W. Howard, Stanley D. Kosanke, Xiaoshan Feng and Xiaohe Yang. Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice. Journal of Experimental & Clinical Cancer Research (2017)36:6. Author Affiliations Julius L. Chambers Biomedical/Biotechnology Research Institute, Department of Biological and Biomedical […]
Cancerous inhibitor of PP2A is a novel molecular target and resistance factor of Lapatinib, Journal of Cancer Research, April 22, 2015, Ming Zhao, Amanda Blackwelder, Harry Lee, and Xiaohe Yang Biomedical/Biotechnology Research Institute and Department of Biology, North Carolina Central University, Kannapolis, NC. Abstract 3557: Cancerous inhibitor of PP2A is a novel molecular target and resistance factor of Lapatinib Abstract […]